Jim Cramer On Bristol-Myers Squibb: “Waiting For It To Bottom”

Syeda Seirut Javed

Fri, May 16, 2025, 12:09 PM 2 min read

Among the information stocks discussed by Cramer during the occurrence connected May 14, Bristol-Myers Squibb Company (NYSE:BMY) was archetypal connected his database arsenic helium said:

“Let's get started with the stocks that sold disconnected hard today, due to the fact that I deliberation it's truly important, due to the fact that you cognize most, if not all, of these companies. Why don't we commencement with Bristol Myers, which we ain for the Charitable Trust? Now here's a cause institution with a decent oncology franchise that happens to beryllium facing what's known arsenic a immense patent cliff, alright… meaning it's astir to person immoderate highly lucrative drugs suffer their patent protection, truthful not marque them overmuch wealth astatine all. We ain it successful portion due to the fact that of the yield. They're paying you to hold for caller drugs that crook things around. The main 1 is COBENFY. It's a perchance revolutionary cause that treats immoderate pugnacious neurological problems, including schizophrenia. Now we sold immoderate of this banal erstwhile it had this ridiculous spike close here… immoderate bizarre rotation into safety, but present Bristol's successful the mid-40s. Now, we haven't bought backmost each of the banal that we sold. We're waiting for it to bottommost due to the fact that its astir caller studies utilizing COBENFY, it's 1 study, it came up snake eyes. Management has said implicit and implicit again that it tin wage the dividend, which gives you a 5.6% yield. Why not bargain more? Honestly, due to the fact that I deliberation it tin spell little inactive without grounds that COBENFY is doing better.”

A pharmacy shelves stocked with pharmaceutical drugs awaiting distribution.

Bristol-Myers Squibb Company (NYSE:BMY) develops treatments for antithetic diseases crossed respective aesculapian fields.

While we admit the imaginable of BMY to grow, our condemnation lies successful the content that immoderate AI stocks clasp greater committedness for delivering higher returns and person constricted downside risk.  If you are looking for an AI banal that is much promising than BMY and that has 100x upside potential, cheque retired our study astir this cheapest AI stock.

READ NEXT: Jim Cramer Put These 8 Stocks Under a Microscope Recently and Jim Cramer Commented connected These 6 Natural Gas Players

Disclosure: None.